Updated Jul 16, 2026
Carroll Jill has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $5.00M.
Jill Carroll is associated with Arcellx, Inc., a biotechnology company focused on developing innovative cell therapies for cancer treatment. Further details about her specific role or contributions within the company are not readily available.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-01 | AVLN | Avalyn Pharma Inc. | P — Open-market purchase | 277.8K | $18.00 | $5.00M |
| 2026-05-01 | AVLN | Avalyn Pharma Inc. | J — Other acquisition / disposition | 489.5K | — | |
| 2026-05-01 | AVLN | Avalyn Pharma Inc. | J — Other acquisition / disposition | 1.42M | — | |
| 2026-04-28 | ACLX | Arcellx, Inc. | J — Other acquisition / disposition | 1.48M | — |
Jill Carroll is associated with Arcellx, Inc., a biotechnology company focused on developing innovative cell therapies for cancer treatment. Further details about her specific role or contributions within the company are not readily available.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 1 open-market purchases ($5.00M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Carroll Jill profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.